Avidity Biosciences, Inc. (RNA)
NASDAQ: RNA · Real-Time Price · USD
34.02
+0.26 (0.77%)
At close: Jul 21, 2025, 4:00 PM
34.38
+0.36 (1.06%)
After-hours: Jul 21, 2025, 7:25 PM EDT
Avidity Biosciences Market Cap
Avidity Biosciences has a market cap or net worth of $4.10 billion as of July 21, 2025. Its market cap has decreased by -0.47% in one year.
Market Cap
4.10B
Enterprise Value
2.73B
1-Year Change
-0.47%
Ranking
Category
Stock Price
$34.02
Market Cap Chart
Since June 12, 2020, Avidity Biosciences's market cap has increased from $1.01B to $4.10B, an increase of 307.02%. That is a compound annual growth rate of 31.67%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 18, 2025 | 4.07B | 17.29% |
| Dec 31, 2024 | 3.47B | 417.36% |
| Dec 29, 2023 | 670.62M | -54.52% |
| Dec 30, 2022 | 1.47B | 32.27% |
| Dec 31, 2021 | 1.11B | 16.40% |
| Dec 31, 2020 | 957.68M | -4.94% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 692.79B |
| Johnson & Johnson | 393.87B |
| AbbVie | 334.31B |
| Novo Nordisk | 287.38B |
| UnitedHealth Group | 256.40B |
| Novartis AG | 223.49B |
| Abbott Laboratories | 215.17B |
| AstraZeneca | 214.61B |